-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30

Benzinga·08/14/2026 16:08:35
語音播報
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.